New Findings on the Sinclair Nanopig™ in Safety Studies
Recent Scientific Data Challenges the Status Quo
Our most recent white paper presents detailed genomic, proteomic, and functional data on the Sinclair Nanopig™’s metabolism and immune systems. These findings validate this animal model as a valuable tool for regulatory pharmacology and drug safety, enhancing cross-species assessments and improving understanding of drug metabolism and potential toxicities.
The groundbreaking data also supports the use of the Sinclair Nanopig™ to reduce reliance on traditional non-rodent models in drug development.
Questions? Consult with one of our experts.
You may also be interested in the following resources: